Chinese biotech startup Bluepha has announced a $30m Series B funding round led by Lightspeed China Partners and GL Ventures. New investors Septwolves Venture Capital and Trinity Innovation Fund as well as existing investors Frees Fund, Qianhai FOF, Qihang Industrial Investment Fund and Frontier Enterprise Investment Fund joined the latest round.
The funding, the largest to be raised in a single round by a Chinese startup in the field of synthetic biology (SynBio), will mostly be used to build a factory that is expected to produce 10,000 tons of fully biodegradable polyhydroxyalkanoate (PHA...
The funding, the largest to be raised in a single round by a Chinese startup in the field of synthetic biology (SynBio), will mostly be used to build a factory that is expected to produce 10,000 tons of fully biodegradable polyhydroxyalkanoate (PHA...
